Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 14 Similar Profiles
Pancreatic Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Sarcoma Medicine & Life Sciences
Radiation Medicine & Life Sciences
Fluorouracil Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2000 2021

Research Output 1988 2017

  • 3926 Citations
  • 36 Scopus h-Index
  • 114 Article
  • 9 Review article
  • 2 Comment/debate
  • 2 Letter

A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor

Bendell, J. C., Javle, M., Bekaii-Saab, T. S., Finn, R. S., Wainberg, Z. A., Laheru, D. A., Weekes, C. D., Tan, B. R., Khan, G. N., Zalupski, M. M., Infante, J. R., Jones, S., Papadopoulos, K. P., Tolcher, A. W., Chavira, R. E., Christy-Bittel, J. L., Barrett, E. & Patnaik, A. Feb 28 2017 In : British Journal of Cancer. 116, 5, p. 575-583 9 p.

Research output: Contribution to journalArticle

Maximum Tolerated Dose
Biliary Tract Neoplasms
Neoplasms
Pharmacokinetics
Biopsy
1 Citations

A phase I trial of cabozantinib and gemcitabine in advanced pancreatic cancer

Zhen, D. B., Griffith, K. A., Ruch, J. M., Camphausen, K., Savage, J. E., Kim, E. J., Sahai, V., Simeone, D. M. & Zalupski, M. M. Dec 1 2016 In : Investigational New Drugs. 34, 6, p. 733-739 7 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Maximum Tolerated Dose
Adenocarcinoma
Disease-Free Survival
Biological Markers
Adjuvant Chemotherapy
Sarcoma
Cysteine
Blood Proteins
Recurrence
1 Citations

Treatment-related Hypertension as a Pharmacodynamic Biomarker for the Efficacy of Bevacizumab in Advanced Pancreas Cancer: A Pooled Analysis of 4 Prospective Trials of Gemcitabine-based Therapy with Bevacizumab

Pant, S., Martin, L. K., Geyer, S., Wei, L., Van Loon, K., Sommovilla, N., Zalupski, M., Iyer, R., Fogelman, D., Ko, A. H. & Bekaii-Saab, T. 2016 In : American Journal of Clinical Oncology: Cancer Clinical Trials. 39, 6, p. 614-618 5 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Biological Markers
Hypertension
Clinical Trials
Neoplasms

A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy-naïve Pancreatic Adenocarcinoma

Cohen, S. J., Zalupski, M. M., Conkling, P., Nugent, F., Ma, W. W., Modiano, M., Pascual, R., Lee, F. C., Wong, L. & Hersh, E. Dec 24 2015 In : American Journal of Clinical Oncology: Cancer Clinical Trials.

Research output: Contribution to journalArticle

Multicenter Studies
Adenocarcinoma
Placebos
Drug Therapy
Confidence Intervals